Agile and flexible to accelerate value creation
Jubilant Therapeutics is open for partnering or strategic collaborations with biotech, pharma, academia, research labs for:
-
Accelerating clinical development and market launch of our ongoing programs
-
Discovery/development of new programs in synergistic areas
-
Conducting research with our drug candidates either as monotherapy or in combination to improve existing therapies in cancer and auto-immune disorders
-
In-licensing discovery assets
-
Research and pre-clinical studies